The relationships between alpha receptor block, inhibition of norepinephrine uptake and the release and metabolism of 3H-norepinephrine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D003042:Cocaine / Q000494:pharmacology; D003641:Deamination; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D008333:Mandelic Acids / Q000378:metabolism; D008745:Methylation; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009647:Normetanephrine / Q000378:metabolism; D010477:Perfusion; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D013154:Spleen / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000317:Adrenergic alpha-Antagonists; D008333:Mandelic Acids; D009647:Normetanephrine; D010643:Phenoxybenzamine; D014316:Tritium; D004295:Dihydroxyphenylalanine; D003042:Cocaine; D009638:Norepinephrine; D010646:Phentolamine